InMode (INMD) Free Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.96% |
| Dec 31, 2025 | -5.66% |
| Sep 30, 2025 | 1.28% |
| Jun 30, 2025 | 71.92% |
| Mar 31, 2025 | -56.76% |
| Dec 31, 2024 | -4.25% |
| Sep 30, 2024 | -19.33% |
| Jun 30, 2024 | 74.63% |
| Mar 31, 2024 | -60.41% |
| Dec 31, 2023 | 47.11% |
| Sep 30, 2023 | -21.81% |
| Jun 30, 2023 | 147.94% |
| Mar 31, 2023 | -62.68% |
| Dec 31, 2022 | 25.01% |
| Sep 30, 2022 | -3.29% |
| Jun 30, 2022 | 47.87% |
| Mar 31, 2022 | -39.42% |
| Dec 31, 2021 | 4.63% |
| Sep 30, 2021 | 7.72% |
| Jun 30, 2021 | 88.89% |
| Mar 31, 2021 | -40.10% |
| Dec 31, 2020 | 37.38% |
| Sep 30, 2020 | 1,854.65% |
| Jun 30, 2020 | -75.08% |
| Mar 31, 2020 | -77.46% |
| Dec 31, 2019 | 103.36% |
| Sep 30, 2019 | -27.00% |
| Jun 30, 2019 | 490.25% |
| Mar 31, 2019 | -67.02% |
| Dec 31, 2018 | 30.67% |
| Sep 30, 2018 | -43.65% |